U.S. overdose deaths involving psychostimulants other than cocaine, largely methamphetamine, increased 180% among adults under age 65 between 2015 and 2019, to 15,489, according to a study by the National Institute on Drug Abuse published this week in JAMA Psychiatry. The number of people reporting methamphetamine use increased 43% over the period, suggesting that increases in methamphetamine use disorder, frequent use and use of other drugs at the same time may be contributing to the rise in deaths, the authors said.

“What makes these data even more devastating is that currently, there are no approved medications to treat methamphetamine use disorder,” said Emily Einstein, chief of NIDA’s Science Policy Branch and a co-author of the study. 
 

Related News Articles

Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
The AHA Oct. 24  announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention as part of its National…
Headline
The Dr. Lorna Breen Heroes’ Foundation Sept. 24 recognized 34 licensure boards and 375 hospitals for changing invasive and stigmatizing mental health questions…
Headline
Mary Thompson — a member of AHA’s Committee on Behavioral Health and president of Trillium Place, a mental health and addiction recovery organization…
Blog
More than 16 years ago, the U.S. House of Representatives designated July as National Minority Mental Health Awareness Month. Inspired by the work of author…
Headline
The Substance Abuse and Mental Health Services Administration July 24 announced it is awarding $45.1 million in grants toward various behavioral health…